Trizentrische Analyse von Kofaktoren und Komorbidität des Pyoderma gangraenosum

Das Pyoderma gangraenosum (PG) ist eine seltene, inflammatorische destruktiv‐ulzerierende neutrophile Erkrankung mit weitgehend unklarer Pathophysiologie.

[1]  A. Rommel,et al.  Gesundheitliche Lage und Gesundheitsverhalten von Menschen mit Migrationshintergrund. Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1) , 2015 .

[2]  J. Dissemond,et al.  Therapie des Pyoderma gangraenosum in Deutschland: Resultate einer Befragung von Experten , 2015 .

[3]  J. Dissemond,et al.  Therapy of pyoderma gangrenosum in Germany: results of a survey among wound experts , 2015, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[4]  I. Gonçalves,et al.  Chronic Inflammation and Atherosclerosis , 2015 .

[5]  J. Klode,et al.  Diagnostic criteria for pyoderma gangrenosum: results of a survey among dermatologic wound experts in Germany , 2014, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[6]  J. Klode,et al.  Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients , 2013, Orphanet Journal of Rare Diseases.

[7]  C. Weber,et al.  Chronische Entzündung und Atherosklerose , 2013, Deutsche Medizinische Wochenschrift.

[8]  H. Neuhauser,et al.  [Blood pressure in Germany 2008-2011: results of the German Health Interview and Examination Survey for Adults (DEGS1)]. , 2013, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

[9]  H. Neuhauser,et al.  Blutdruck in Deutschland 2008–2011 , 2013, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[10]  S. Langan,et al.  Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. , 2012, The Journal of investigative dermatology.

[11]  Manuel J. Amador-Patarroyo,et al.  Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. , 2012, Journal of autoimmunity.

[12]  J. Dissemond,et al.  Untersuchung neuer Kofaktoren bei 49 Patienten mit Pyoderma gangraenosum , 2012 .

[13]  J. Klode,et al.  Investigation of new co‐factors in 49 patients with pyoderma gangrenosum , 2012, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[14]  T. Ruzicka,et al.  Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome. , 2012, Journal of the American Academy of Dermatology.

[15]  E. Maverakis,et al.  The Etiology of Paraneoplastic Autoimmunity , 2012, Clinical Reviews in Allergy & Immunology.

[16]  J. Klode,et al.  Relationship between the seasonal onset of chronic venous leg ulcers and climatic factors , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[17]  A. Qureshi,et al.  Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients , 2011, The British journal of dermatology.

[18]  P. Marrack,et al.  Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c⁺ B-cell population is important for the development of autoimmunity. , 2011, Blood.

[19]  D. Liew,et al.  Pyoderma gangrenosum requiring inpatient management: A report of 26 cases with follow up , 2011, The Australasian journal of dermatology.

[20]  H. Lehnert,et al.  Leptin and the skin: a new frontier , 2010, Experimental dermatology.

[21]  J. Piette,et al.  Longest Form of CCTG Microsatellite Repeat in the Promoter of the CD2BP1/PSTPIP1 Gene Is Associated with Aseptic Abscesses and with Crohn Disease in French Patients , 2010, Digestive Diseases and Sciences.

[22]  Paul M Ridker,et al.  Inflammation in atherosclerosis: from pathophysiology to practice. , 2009, Journal of the American College of Cardiology.

[23]  G. Plewig,et al.  Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin‐1 receptor antagonist anakinra , 2009, The British journal of dermatology.

[24]  A. Heiligenhaus,et al.  ["TRECID", TNFalpha related chronic inflammatory diseases - a new multiple diseases bridging concept]. , 2009, Deutsche medizinische Wochenschrift.

[25]  Yidi Su,et al.  Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome): report of a sporadic case without an identifiable mutation in the CD2BP1 gene. , 2009, Journal of the American Academy of Dermatology.

[26]  E. Ruocco,et al.  Pyoderma gangrenosum: an updated review , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[27]  S. Martín-Orúe,et al.  Use of mannanoligosaccharides and zinc chelate as growth promoters and diarrhea preventative in weaning pigs: Effects on microbiota and gut function. , 2008, Journal of animal science.

[28]  M. Lorenzo,et al.  Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes. , 2008, Journal of animal science.

[29]  C. Probert,et al.  T‐cell receptor repertoire in pyoderma gangrenosum: evidence for clonal expansions and trafficking , 2007, The British journal of dermatology.

[30]  U. Wollina.  Pyoderma gangrenosum – a review , 2007, Orphanet journal of rare diseases.

[31]  S. Grabbe,et al.  Differentialdiagnosen des Ulcus cruris , 2006 .

[32]  S. Grabbe,et al.  Differential diagnosis of leg ulcers , 2006 .

[33]  M. Denda,et al.  Dry environment increases mast cell number and histamine content in dermis in hairless mice , 2003, The British journal of dermatology.

[34]  M. Mokni,et al.  Pyoderma gangrenosum: a report of 21 cases , 2002, International journal of dermatology.

[35]  C. Whitacre.  Sex differences in autoimmune disease , 2001, Nature Immunology.

[36]  A. Fleischer,et al.  Pyoderma Gangrenosum A Comparison of Typical and Atypical Forms with an Emphasis on Time to Remission. Case Review of 86 Patients from 2 Institutions , 2000, Medicine.

[37]  P. Driesch,et al.  Pyoderma gangrenosum: a report of 44 cases with follow‐up , 1997, The British journal of dermatology.

[38]  E. Bröcker,et al.  [Pyoderma gangraenosum]. , 1996, Zentralblatt fur Chirurgie.

[39]  W. Bergfeld,et al.  Pyoderma gangrenosum: a review. , 1988, Journal of the American Academy of Dermatology.

[40]  E. Gordon-Smith,et al.  Pyoderma gangrenosum in myelodysplasia and acute leukaemia. , 1985, Postgraduate medical journal.

[41]  W. Su,et al.  Pyoderma gangrenosum: a review of 86 patients. , 1985, The Quarterly journal of medicine.